Immunization of common marmosets with Epstein-Barr virus (EBV) envelope glycoprotein gp340: effect on viral shedding following EBV challenge

Journal of Medical Virology
C CoxN Wedderburn

Abstract

Epstein-Barr virus (EBV), the cause of infectious mononucleosis, is involved in the pathogenesis of several human cancers, the highest frequency of association being found in undifferentiated nasopharyngeal carcinoma and endemic Burkitt's lymphoma. The development of animal models in which potential vaccines can be tested is important. EBV infection of the common marmoset, using the M81 strain originally derived from a patient with nasopharyngeal carcinoma, induces a carrier state in this animal. Persistent infection is characterized by the production of antibodies to viral antigens, and the secretion of EBV DNA into buccal fluids. Following immunization with envelope glycoprotein gp340 derived from a bovine papilloma virus expression vector, prior to EBV infection, viral DNA was detected significantly less frequently in the buccal fluids of immunized, than of nonimmunized, infected animals, indicating that although the carrier state had not been abolished, it had been altered. A reduction in virus load was also observed when offspring of seronegative, and on occasion seropositive, parents were immunized neonatally, before EBV challenge.

References

Apr 1, 1976·Journal of the National Cancer Institute·M A Epstein
Jan 1, 1992·Vaccine·A J Morgan
Jan 15, 1989·International Journal of Cancer. Journal International Du Cancer·Q Y YaoA B Rickinson
Sep 1, 1989·Journal of Medical Virology·A J MorganM A Epstein
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J W GratamaI Ernberg
Jan 15, 1985·International Journal of Cancer. Journal International Du Cancer·Q Y YaoM A Epstein
Jan 15, 1985·International Journal of Cancer. Journal International Du Cancer·Q Y YaoM A Epstein
Aug 1, 1986·The Journal of Clinical Endocrinology and Metabolism·W M WiersingaE A van Royen
Mar 1, 1966·Journal of Bacteriology·G Henle, W Henle
Dec 1, 1984·The Journal of Infectious Diseases·N WedderburnG de Thé
Jun 1, 1996·The Journal of General Virology·C CoxN Wedderburn
Aug 1, 1996·Immunity·G KhanD A Thorley-Lawson
Oct 16, 1996·Journal of the National Cancer Institute·S B SpringJ Gruber
Jul 1, 1997·Journal of Virology·E M MiyashitaD A Thorley-Lawson
Jan 1, 1997·Pathology Oncology Research : POR·Christian JassoySieghart Sopper

❮ Previous
Next ❯

Citations

May 15, 2013·Vaccine·Xinle CuiClifford M Snapper
Dec 4, 2003·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·A C Weston, J C Prolla
Jul 16, 2010·Archives of Oral Biology·R A P M PereraC S P Tsang
Jun 21, 2002·The Journal of General Virology·Hal B JensonMichael Mackett
Nov 25, 2011·PLoS Pathogens·Bénédicte MachielsLaurent Gillet
Feb 12, 2015·Clinical & Translational Immunology·Jeffrey I Cohen
Mar 13, 2019·Frontiers in Oncology·Dwain G van ZylHenri-Jacques Delecluse
Feb 23, 2021·Frontiers in Immunology·Neelakshi R Jog, Judith A James

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.